Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition
暂无分享,去创建一个
Y. Goshima | T. Miyakawa | K. Takao | Toshifumi Yamamoto | N. Yamashita | P. Kolattukudy | Aoi Takahashi
[1] G. Salmon,et al. Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.
[2] Y. Goshima,et al. Phosphorylation of CRMP2 is involved in proper bifurcation of the apical dendrite of hippocampal CA1 pyramidal neurons , 2013, Developmental neurobiology.
[3] T. Abe,et al. CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus , 2012, Developmental neurobiology.
[4] W. Hennah,et al. Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. , 2012, Human molecular genetics.
[5] Y. Goshima,et al. Collapsin Response Mediator Proteins Regulate Neuronal Development and Plasticity by Switching Their Phosphorylation Status , 2012, Molecular Neurobiology.
[6] K. Mikoshiba,et al. Phosphorylation of CRMP2 (Collapsin Response Mediator Protein 2) Is Involved in Proper Dendritic Field Organization , 2012, The Journal of Neuroscience.
[7] S. Carr,et al. Cdk5 Is Required for Memory Function and Hippocampal Plasticity via the cAMP Signaling Pathway , 2011, PloS one.
[8] T. Hortobágyi,et al. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. , 2011, Brain : a journal of neurology.
[9] Taisuke Kawasaki,et al. Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits , 2011, Neuron.
[10] Y. Goshima,et al. CRMP5 (Collapsin Response Mediator Protein 5) Regulates Dendritic Development and Synaptic Plasticity in the Cerebellar Purkinje Cells , 2011, The Journal of Neuroscience.
[11] Takuya Takahashi,et al. Serotonin mediates cross-modal reorganization of cortical circuits , 2010, Neuroscience Research.
[12] Andreas Meyer-Lindenberg,et al. The neurobiology of schizophrenia: new leads and avenues for treatment , 2010, Current Opinion in Neurobiology.
[13] L. Garey. When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits , 2010, Journal of anatomy.
[14] T. Miyakawa,et al. Elevated Plus Maze for Mice , 2008, Journal of visualized experiments : JoVE.
[15] K. Nakayama,et al. Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. , 2008, Human molecular genetics.
[16] K. Fukunaga,et al. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders , 2008, European Psychiatry.
[17] M. Baudry,et al. The FASEB Journal • Research Communication CRMP3 is required for hippocampal CA1 dendritic organization and plasticity , 2022 .
[18] P. Fletcher,et al. The amphetamine-induced sensitized state as a model of schizophrenia , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] J. Honnorat,et al. Regulation of Spine Development by Semaphorin3A through Cyclin-Dependent Kinase 5 Phosphorylation of Collapsin Response Mediator Protein 1 , 2007, The Journal of Neuroscience.
[20] J. Shih,et al. Mice Deficient in Collapsin Response Mediator Protein-1 Exhibit Impaired Long-Term Potentiation and Impaired Spatial Learning and Memory , 2007, The Journal of Neuroscience.
[21] K. Mikoshiba,et al. Collapsin Response Mediator Protein 1 Mediates Reelin Signaling in Cortical Neuronal Migration , 2006, The Journal of Neuroscience.
[22] Paul Antoine Salin,et al. Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1−/– mice , 2006, Genes to cells : devoted to molecular & cellular mechanisms.
[23] T. Miyakawa,et al. Investigating Gene‐to‐Behavior Pathways in Psychiatric Disorders , 2006, Annals of the New York Academy of Sciences.
[24] G D Pearlson,et al. Neurobiology of schizophrenia , 2000, Annals of neurology.
[25] B. Eickholt,et al. Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo* , 2006, Journal of Biological Chemistry.
[26] Kyla Pennington,et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.
[27] S. Hirsch,et al. Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics , 2006, Experimental Brain Research.
[28] Jie Qin,et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice , 2005, Nature Neuroscience.
[29] R. Buchanan,et al. Dihydropyrimidinase‐related protein 2 (DRP‐2) gene and association to deficit and nondeficit schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[30] David A Lewis,et al. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.
[31] R. Rodriguiz,et al. Neural Cell Adhesion Molecule-secreting Transgenic Mice Display Abnormalities in Gabaergic Interneurons and Alterations in Behavior , 2022 .
[32] S. Fatemi,et al. Reelin glycoprotein: structure, biology and roles in health and disease , 2005, Molecular Psychiatry.
[33] K. Mikoshiba,et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[34] K. Kaibuchi,et al. GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.
[35] L. Tsai,et al. Cyclin-Dependent Kinase 5 Phosphorylates the N-Terminal Domain of the Postsynaptic Density Protein PSD-95 in Neurons , 2004, The Journal of Neuroscience.
[36] M. Noda,et al. Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization , 2003, The European journal of neuroscience.
[37] K. Kaibuchi,et al. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.
[38] J. Radulovic,et al. Cyclin-Dependent Kinase 5 Is Required for Associative Learning , 2002, The Journal of Neuroscience.
[39] R. Gainetdinov,et al. Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.
[40] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[41] M. Noda,et al. Molecular Characterization of CRMP5, a Novel Member of the Collapsin Response Mediator Protein Family* , 2000, The Journal of Biological Chemistry.
[42] Yogesh K. Dwivedi,et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.
[43] S. Yanagi,et al. Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. , 2000, The Journal of biological chemistry.
[44] J. Swanson,et al. Attention deficit/hyperactivity disorder: characteristics, interventions and models. , 2000, Neurotoxicology and teratology.
[45] P. Greengard,et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.
[46] M. Laruelle,et al. Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.
[47] Yogesh K. Dwivedi,et al. The phenotypic characteristics of heterozygous reeler mouse. , 1999, Neuroreport.
[48] Yogesh K. Dwivedi,et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Crawley,et al. Inbred strain differences in prepulse inhibition of the mouse startle response , 1997, Psychopharmacology.
[50] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Strittmatter,et al. A Family of Rat CRMP Genes Is Differentially Expressed in the Nervous System , 1996, The Journal of Neuroscience.
[52] A. Sobel,et al. Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] S. Hockfield,et al. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] Fumio Nakamura,et al. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 , 1995, Nature.
[55] Joseph E LeDoux,et al. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.
[56] D L Braff,et al. Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.
[57] 廣島 幸彦. 膵癌の浸潤、転移過程におけるCollapsin Response Mediator Protein4の役割 , 2013 .
[58] 吉村 武. GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity , 2005 .
[59] J. Lieberman,et al. Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.
[60] Greg D. Gale,et al. Hippocampus and contextual fear conditioning: Recent controversies and advances , 2001, Hippocampus.
[61] R. Yolken,et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.
[62] Joseph E LeDoux,et al. Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus , 2000, Nature Neuroscience.
[63] D. Lewis,et al. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.
[64] R. Faull,et al. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia , 2000, Molecular Psychiatry.
[65] M. Nonaka,et al. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. , 1996, Gene.